CELZ — CREATIVE MED TECHNOLOGY HLDG
As of Q2 2026, 3 SEC-registered investment managers reported holding CELZ (CREATIVE MED TECHNOLOGY HLDG) in their latest 13F filings, with a combined reported value of $41.15K across 28.37K shares. That is -35.6% by share count (-15.70K shares) versus the previous quarter, while reported value moved -54.7%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 added to existing stakes, 2 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
CELZ is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 25.87K | $50.70K | 0.00% | Hold |
| Two Sigma Investments history | Q3 2024 | 13.11K | $40.63K | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 25.80K | $37.42K | 0.00% | Reduce |
| Citadel Advisors history | Q4 2025 | 17.46K | $34.22K | 0.00% | New |
| Northern Trust Corp history | Q2 2025 | 11.71K | $31.02K | 0.00% | New |
| Wells Fargo & Co history | Q1 2026 | 5.00K | $10.30K | 0.00% | New |
| Bank of America Corp history | Q4 2025 | 5.13K | $10.06K | 0.00% | Add |
| Citigroup Inc history | Q2 2022 | 6.65K | $5.00K | 0.00% | Reduce |
| Millennium Management history | Q3 2022 | 10.03K | $4.00K | 0.00% | New |
| UBS Group AG history | Q2 2026 | 2.06K | $2.99K | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 514 | $745 | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q1 2026 | 250 | $515 | 0.00% | New |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- Wells Fargo & Co sold 5.00K sh · $10.30K
- Fidelity Management & Research (FMR) sold 250 sh · $515
Fund Position History — shares by quarter (top 12 funds)
| Fund | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | — | 34.34K | 34.34K | 34.34K | 124.22K | — | — | — | — | — | — | 10.31K | 18.27K | 20.88K | 23.26K | 28.47K | 38.29K | 25.80K |
| UBS Group AG | 9.16K | — | 10.78K | 30.90K | — | 20 | 1.09K | 1.04K | 3.06K | — | 2.73K | 1 | 2 | 2 | 2 | 11 | 1 | 2.06K |
| Morgan Stanley | — | — | — | 200 | 200 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 34 | 34 | 534 | 514 |
| Citadel Advisors | — | — | 257.87K | — | — | — | — | — | — | — | — | — | — | 11.14K | — | 17.46K | — | — |
| Fidelity Management & Research (FMR) | — | — | 5.17K | — | 915 | — | — | — | — | — | — | — | — | — | 200 | — | 250 | — |
| Bank of America Corp | 1.07K | 1.07K | 1.07K | 1.07K | 1.07K | — | — | — | 108 | 129 | 131 | 122 | 122 | 133 | 131 | 5.13K | — | — |
| Vanguard Group | 25.17K | 61.05K | 61.05K | 61.05K | 61.05K | 17.63K | 17.63K | 17.63K | 17.63K | 17.63K | 17.63K | 17.63K | 17.63K | 17.63K | 25.87K | 25.87K | — | — |
| Wells Fargo & Co | 36 | 59 | 93 | 96 | 97 | 10 | 30 | 11 | 11 | — | — | — | — | — | — | — | 5.00K | — |
| Two Sigma Investments | — | — | — | — | — | — | — | — | 14.90K | 14.81K | 13.11K | — | — | — | — | — | — | — |
| Citigroup Inc | 12.16K | 6.65K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Millennium Management | — | — | 10.03K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Northern Trust Corp | — | 10.02K | 17.06K | 17.06K | 17.06K | — | — | — | — | — | — | — | — | 11.71K | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details